Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Johansen MY, MacDonald CS, Hansen KB, Karstoft K, Christensen R, Pedersen M, Hansen LS, Zacho M, Wedell-Neergaard AS, Nielsen ST, Iepsen UW, Langberg H, Vaag AA, Pedersen BK, Ried-Larsen M.
JAMA. 2017 Aug 15;318(7):637-646. doi: 10.1001/jama.2017.10169.
PMID:28810024
Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.
Ling J, Ng JKC, Chan JCN, Chow E.
Front Endocrinol (Lausanne). 2022 Apr 22;13:869899. doi: 10.3389/fendo.2022.869899. eCollection 2022.
PMID:35528010
Non-insulin therapies in addition to insulin in Type 1 DM treatment.
Llano A, McKay GA.
Br Med Bull. 2020 Jul 9;134(1):54-62. doi: 10.1093/bmb/ldaa011.
PMID:32409841
Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial.
Blevins T, Dahl D, Pérez Manghi FC, Murthy S, Ortiz Carrasquillo R, Li X, Chang AM, Carr MC, Katz M.
Lancet. 2025 Jun 28;405(10497):2290-2301. doi: 10.1016/S0140-6736(25)01069-4. Epub 2025 Jun 22.
PMID:40562048
Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus.